Ocular Therapeutix shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Ocular Therapeutix
Tip: Access up to 7 years of quarterly data
All positions including Ocular Therapeutix held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ocular Therapeutix by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.2M | 276k | 11.69 |
| 2025-03-31 | $2.5M | 338k | 7.33 |
| 2024-12-31 | $1.6M | 189k | 8.54 |
| 2024-09-30 | $736k | 85k | 8.70 |
| 2024-06-30 | $584k | 85k | 6.84 |
| 2024-03-31 | $630k | 69k | 9.10 |
| 2023-12-31 | $303k | 68k | 4.46 |
| 2023-09-30 | $213k | 68k | 3.14 |
| 2023-06-30 | $331k | 64k | 5.16 |
| 2023-03-31 | $26k | 4.9k | 5.29 |
| 2022-12-31 | $130k | 46k | 2.81 |
| 2022-06-30 | $178k | 44k | 4.03 |
| 2022-03-31 | $224k | 45k | 4.95 |
| 2021-12-31 | $256k | 37k | 6.94 |
| 2021-03-31 | $661k | 40k | 16.39 |
| 2020-12-31 | $1.8M | 82k | 22.06 |
| 2020-09-30 | $1.8M | 228k | 7.81 |
| 2020-06-30 | $144k | 17k | 8.35 |
| 2020-03-31 | $67k | 14k | 4.97 |
| 2019-12-31 | $54k | 14k | 3.97 |
| 2019-09-30 | $41k | 14k | 3.02 |
| 2019-06-30 | $1.3M | 293k | 4.45 |
| 2019-03-31 | $70k | 18k | 3.94 |
| 2018-12-31 | $34k | 8.5k | 3.99 |
| 2018-09-30 | $361k | 53k | 6.85 |
| 2018-06-30 | $509k | 76k | 6.74 |
| 2018-03-31 | $38k | 5.8k | 6.55 |
| 2017-12-31 | $120k | 27k | 4.47 |
| 2017-06-30 | $3.1M | 339k | 9.27 |
| 2017-03-31 | $3.4M | 366k | 9.28 |